Edmund Ingham
Author ProfileClaim This Author Profile
Prove ownership by publishing #HashtagPLUS and this profile link on your author page or an article under your byline. A moderator or admin will review the request before it merges into your real HashtagPLUS username.
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Roche To Acquire PathAI: Smart Dealmaking By A Smart Pharma
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: UniQure Q1 Earnings Review: Limited Progress With FDA, But UK Approval In Play
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: FDA's Makary On Brink: Why Biotech And Pharma Investors Shouldn't Panic (Or Celebrate)
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Cencora Earnings Review: The Selloff Was Overdone In My View
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Pfizer Q1 Earnings Review: Stuck In Second Gear, But Dividend Helps
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Eli Lilly: Stellar Q1 Earnings Put Pharma In Class Of Its Own - It's Ok To Buy Today
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: AstraZeneca: Q1 Earnings Analysis: An Excellent Long-Term Buy And Hold
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit